PlaqueTec
PlaqueTec

PlaqueTec

Pioneering intracoronary liquid biopsy to identify inflammatory drivers of cardiovascular disease.

ActiveCambridge, United Kingdom

About

PlaqueTec is a medtech company focused on developing and utilizing intracoronary liquid biopsy to identify the inflammatory drivers of cardiovascular disease (CVD). They are building a proprietary cardiovascular data lake called BioCarta, which is a repository of unique intracoronary proteomic and clinical data.

Key facts

At-a-glance profile data

Website
plaquetec.com
Headquarters
Cambridge, England, United Kingdom
Total funding
$5M (Funding Round)
Business model
B2B

Funding rounds

Funding rounds raised by PlaqueTec
DateRoundAmountLead investors
27 Apr 2026Funding Round$5M-

Tech stack

Detected on plaquetec.com, last scanned 18 Sept 2026. Run your own scan

Observability
Sentry
CMS / Builders
Wix
Email provider
Microsoft 365
Add first review

Frequently asked

How much funding has PlaqueTec raised?

PlaqueTec has raised a total of $5M in funding. The most recent round on record is Funding Round.